# Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection

> **NCT04528888** · PHASE3 · UNKNOWN · sponsor: **Massimo Girardis** · enrollment: 210 (estimated)

## Conditions studied

- Covid19
- SARS-CoV Infection
- Pneumonia, Viral
- Coagulopathy

## Interventions

- **DRUG:** Enoxaparin
- **DRUG:** Methylprednisolone
- **DRUG:** unfractionated heparin

## Key facts

- **NCT ID:** NCT04528888
- **Lead sponsor:** Massimo Girardis
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-25
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04528888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04528888, "Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04528888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*